Hiscia Research Institute

Hiscia Research Institute is a Swiss-based research organization dedicated to the development and study of mistletoe-based therapies for cancer. Established in 1949 by the Society for Cancer Research, the institute is the birthplace of Iscador, one of the most widely used integrative oncology treatments in Europe. Hiscia specializes in the pharmaceutical processing of Viscum album (mistletoe) extracts, utilizing a unique fermentation process to enhance therapeutic properties. The institute conducts extensive preclinical and clinical research to investigate the immunomodulatory and cytotoxic effects of mistletoe lectins and viscotoxins. Its operations bridge anthroposophic medicine and conventional oncology, providing evidence-based supportive care options for cancer patients. The institute manages the entire value chain from botanical cultivation and harvesting to GMP-compliant manufacturing.